Clinical Trial Update: Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

View source ↗

Summary

An observational study evaluating the use of ivosidenib for locally advanced or metastatic cholangiocarcinoma with IDH1 R132 mutation after prior systemic thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Ivosidenib (Tibsovo) (ivosidenib)

Snippet

Sponsor: iOMEDICO AG | Conditions: Cholangiocarcinoma | Status: RECRUITING